Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Jan;82(1):121-5.
doi: 10.4269/ajtmh.2010.09-0347.

Severe cysticercal meningitis: clinical and imaging characteristics

Affiliations

Severe cysticercal meningitis: clinical and imaging characteristics

Graciela Cárdenas et al. Am J Trop Med Hyg. 2010 Jan.

Abstract

In disease-endemic areas, severe cysticercal meningitis (SCM) is characterized by intense inflammatory cerebrospinal fluid (CSF) and negative bacterial and fungal cultures. There have been no systematic studies of SCM. We characterized patients with SCM and compare them with neurocysticercosis (NC) patients with mild CSF abnormalities by conducting a nine-year retrospective review at a neurological referral center. Two groups of patients were compared: group A, those with severe CSF pleocytosis > 1,000 cells/mm(3) (n = 12), and group B, those with CSF pleocytosis <or= 1,000 cells/mm(3) (n = 126). All patients had positive CSF results in an enzyme-linked immunosorbent assay for cysticercal antigens and negative CSF cultures for bacteria, fungi, and mycobacteria. Intracranial hypertension, meningeal signs, CSF hypoglycorrachia, and a longer clinical course of NC were more frequently seen in group A. It is likely that SCM often goes unrecognized. Its correct identification may reduce morbidity and risks of unnecessary surgery in patients with chronic NC and CSF shunts.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Fleury A, Dessein A, Preux PM, Dumas M, Tapia G, Larralde C, Sciutto E. Symptomatic human neurocysticercosis: age, sex and exposure factors relating with disease heterogeneity. J Neurol. 2004;251:830–830. - PubMed
    1. Bandres JA, White AC, Samo T, Murphy EC, Harris RL. Extraparenchymal neurocysticercosis: report of five cases and review of literature on management. Clin Infect Dis. 1992;15:799–799. - PubMed
    1. Venkataraman S, Roy AK, Dhamija RM, Sanchetee PC. Cysticercal meningoencephalitis: clinical presentation and autopsy findings. J Assoc Physicians India. 1990;38:763–763. - PubMed
    1. Singh G. Neurocysticercosis in the South-Central America and the Indian subcontinent. A comparative evaluation. Arq Neuropsiquiatr. 1997;55:349–349. - PubMed
    1. Vaz AJ, Hanashiro AS, Chieffi PP, Ferreira AW. Frequency of patients with anti-cysticercus cellulosae antibodies in 5 municipalities of state of São Paulo. Rev Soc Bas Med Trop. 1990;23:97–97. - PubMed

LinkOut - more resources